Table 4 Antibiotic resistance in PVL positive and PVL negative isolates
Antibiotic Class | Antibiotic Name | PVL-positive | PVL-negative | Total % of Resistance | ||
|---|---|---|---|---|---|---|
MIC range (µgml − 1 ) | % of Resistance | MIC range (µgml − 1 ) | % of Resistance | |||
β-lactams | Cefoxitine | 8->256 | 100% | 8->256 | 100% | 100.00% |
Macrolides | Erythromycin | 4->256 | 97.9% | 1->256 | 94.5% | 96.20% |
Quinolones | Ciprofloxacin | < 0.25-8 | 8.3% | < 0.25-16 | 5.4% | 6.85% |
Aminoglycosides | Gentamicin* | < 0.25->256 | 87.5% | 1->256 | 67.2% | 83.75% |
Tetracyclines | Tetracycline | 0.5->256 | 87.5% | 0.5->256 | 80% | 83.75% |
lincomycin | Clindamycin* | 0.25–128 | 83.3% | 0.25–128 | 58.2% | 70.75% |
Glycopeptide | Vancomycin | < 0.25->256 | 25% | < 0.25->256 | 21.8% | 23.4% |
Folic acid inhibitors | Co-trimoxazole | 0.5->256 | 64.6% | 0.5->256 | 50.9% | 57.75% |
Fusidane | Fusidic acid | 4->256 | 97.9% | 4->256 | 96.3% | 97.1% |